Repligen
RGEN
#2270
Rank
โ‚น770.53 B
Marketcap
โ‚น13,688
Share price
-4.48%
Change (1 day)
-4.85%
Change (1 year)
Categories

Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Volume in USD (price x number of shares), data since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚น21.87 M-36.33%
2024โ‚น34.35 M-68.17%
2023โ‚น0.10 B60.05%
2022โ‚น67.43 M90.89%
2021โ‚น35.32 M-76.42%
2020โ‚น0.14 B197.63%
2019โ‚น50.34 M-29.09%
2018โ‚น70.99 M835.37%
2017โ‚น7.59 M22.08%
2016โ‚น6.21 M-19.68%
2015โ‚น7.74 M-7.23%
2014โ‚น8.34 M721.71%
2013โ‚น1.01 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
โ‚น56.21 Mโ‚น0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น8.2 Mโ‚น70.05 M๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น16.57 Mโ‚น0.51 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น31.05 Mโ‚น81.93 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น0.39 Mโ‚น8.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น15.56 Mโ‚น63.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น5.02 Mโ‚น30.19 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น9.3 Mโ‚น18.92 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น8.34 Mโ‚น13.64 M๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น84.22 Mโ‚น0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA